Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Anderson

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Journal of Medicinal Chemistry|August 5, 1994
Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuranA K Ghosh, W J Thompson, P M Fitzgerald, et al.
Journal of Medicinal Chemistry|December 1, 1985
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonistJ R Huff, P S Anderson, J J Baldwin, et al.
International Journal of Peptide and Protein Research|January 1, 1992
NMR and molecular modeling characterization of RGD containing peptidesM J Bogusky, A M Naylor, S M Pitzenberger, et al.
Journal of Medicinal Chemistry|May 1, 1986
Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]+ ++alkanoi c acids and some of their analoguesE J Cragoe, O W Woltersdorf, N P Gould, et al.
Journal of Medicinal Chemistry|December 1, 1989
Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucomaJ J Baldwin, G S Ponticello, P S Anderson, et al.
Journal of Medicinal Chemistry|June 1, 1979
Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acidsW C Randall, K B Streeter, E L Cresson, et al.
Journal of Medicinal Chemistry|March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm laborP D Williams, P S Anderson, R G Ball, et al.
Journal of Medicinal Chemistry|December 1, 1983
Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonistsW S Saari, W Halczenko, S W King, et al.
Journal of Medicinal Chemistry|February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesG E Stokker, A W Alberts, P S Anderson, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokininB E Evans, M G Bock, K E Rittle, et al.
Journal of Medicinal Chemistry|August 5, 1994
Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuranA K Ghosh, W J Thompson, P M Fitzgerald, et al.
Journal of Medicinal Chemistry|December 1, 1985
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonistJ R Huff, P S Anderson, J J Baldwin, et al.
International Journal of Peptide and Protein Research|January 1, 1992
NMR and molecular modeling characterization of RGD containing peptidesM J Bogusky, A M Naylor, S M Pitzenberger, et al.
Journal of Medicinal Chemistry|May 1, 1986
Agents for the treatment of brain edema. 2. [(2,3,9,9a-Tetrahydro-3-oxo-9a-substituted-1H-fluoren-7-yl)oxy]+ ++alkanoi c acids and some of their analoguesE J Cragoe, O W Woltersdorf, N P Gould, et al.
Journal of Medicinal Chemistry|December 1, 1989
Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucomaJ J Baldwin, G S Ponticello, P S Anderson, et al.
Journal of Medicinal Chemistry|June 1, 1979
Quantitative structure-activity relationships involving the inhibition of glycolic acid oxidase by derivatives of glycolic and glyoxylic acidsW C Randall, K B Streeter, E L Cresson, et al.
Journal of Medicinal Chemistry|March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm laborP D Williams, P S Anderson, R G Ball, et al.
Journal of Medicinal Chemistry|December 1, 1983
Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonistsW S Saari, W Halczenko, S W King, et al.
Journal of Medicinal Chemistry|February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesG E Stokker, A W Alberts, P S Anderson, et al.
Pageof 9